Skip to main content

Table 1 Clinicopathologic characteristics of patients with lung cancer

From: MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis

Characteristics All patients (N = 91) (%)
Gender
  Male 38(42 %)
  Female 53(58 %)
Smoking Status
  Nonsmoker 19(21 %)
  Smoker 72(79 %)
Tumor Location
  Central 37(41 %)
  Peripheral 54(59 %)
Tumor Subtypes
  Adenocarcinoma 51(56 %)
  Squamous Cell Carcinoma 40(44 %)
Differentiation
  High 47(52 %)
  Moderate-Poor 44(48 %)
LN Metastasis
  Yes 55(60 %)
  No 36(40 %)
Tumor Size
  >3 cm 57(63 %)
  <3 cm 34(37 %)
TNM Stage
  I-II 39(43 %)
  III-IV 52(57 %)
Mean Survival Time (months) 57.96